does tirzepatide cause sleep issues Tirzepatide, also known as Mounjaro or Zepbound and popular for weight loss, may help treat apnea In adults with obesity but

[9] [12] [17] Developed by Eli Lilly and Company, tirzepatide was approved for treatment of diabetes in the US in May 2022, [9] [12] in the European Union in September 2022, [11] in Canada in November 2022, [18] and in Australia in December 2022

If additional glycemic control is needed, the dosage should be increased to 1.0 mg once weekly

The GLP-1 component helps slow down gastric emptying, which means food stays in your stomach longer, helping you feel full

Using it can carry health risks

Understanding your base tirzepatide dose in milligrams matters when adding other compounds to the protocol

You can adjust for travel